You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

muscarinic

Showing 1 - 25 of 388
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Multiple Sclerosis Trial in London (PIPE-307)

Completed
  • Multiple Sclerosis
  • London, United Kingdom
    Hammersmith Medicines Research
Oct 4, 2022

ive Alzheimer's Medicines - Salbutamol vs Long-acting Muscarinic

Active, not recruiting
  • Chronic Obstructive Pulmonary Disease
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jul 11, 2022

COPD Exacerbation Trial in Copenhagen (Long acting muscarinic antagonists (LAMAs) at bedtime)

Recruiting
  • COPD Exacerbation
  • Long acting muscarinic antagonists (LAMAs) at bedtime
  • Copenhagen, Denmark
    Herlev-Gentofte Hospital
Jan 30, 2023

A Retrospective rEal-life daTa Study to Assess exaceRbations and

Completed
  • COPD
  • COPD Exacerbation
    • Thessaloniki, Greece
      Papanikolaou Hospital of Thessaloniki
    Sep 7, 2022

    Pulmonary Disease, Chronic Obstructive Trial in Brussels (LABA, LAMA)

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Brussels, Belgium
      Erasme University Hospital
    Jun 23, 2023

    Apparent Life-Threatening Event in Infants Under One Year of Age Trial in France (Blood sample for specific analyzes)

    Recruiting
    • Apparent Life-Threatening Event in Infants Under One Year of Age
    • Blood sample for specific analyzes
    • Besançon, France
    • +3 more
    Jun 28, 2022

    Schizophrenia, Schizoaffective Disorder, Healthy Trial in New Haven (11C-EMO - A Novel PET Radiotracer for Muscarinic M1

    Recruiting
    • Schizophrenia
    • +2 more
    • 11C-EMO - A Novel PET Radiotracer for Muscarinic M1 Receptor
    • New Haven, Connecticut
      Connecticut Mental Health Center
    Sep 16, 2022

    Schizophrenia Trial in Boston (CVL-231)

    Recruiting
    • Schizophrenia
    • Boston, Massachusetts
      Massachusetts General Hospital Translational and Clinical Resear
    Jul 6, 2022

    Sjogren's Syndrome, Overactive Bladder Syndrome Trial in Taichung (mirabegron, oxybutynin, tolterodine, solifenacin)

    Recruiting
    • Sjogren's Syndrome
    • Overactive Bladder Syndrome
    • Taichung, Taiwan
      China Medical University Hospital
    Aug 8, 2021

    COPD Trial in Llanelli (Any LABA/LAMA)

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Any LABA/LAMA
    • Llanelli, Carmarthenshire, United Kingdom
      Prince Philip Hospital
    Aug 2, 2022

    Healthy Volunteers Trial in Stockholm (AZD2115, SPIRIVA, [11C]AZ13754366)

    Completed
    • Healthy Volunteers
    • Stockholm, Sweden
      Research Site
    Aug 27, 2021

    Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Taiwan, China
      Health Data Research Center, National Taiwan University
    Jan 3, 2023

    South Korea Using Medical Records to Look at Different

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting Muscarinic Antagonists (LAMA)
    • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
    • Seoul, Korea, Republic of
      Konkuk University Medical Center
    Feb 8, 2022

    Healthy Trial in Winnipeg (Standardized liquid test meal, Atropine + Standardized liquid test meal)

    Completed
    • Healthy
    • Standardized liquid test meal
    • Atropine + Standardized liquid test meal
    • Winnipeg, Manitoba, Canada
      Kalo Medical Clinic
    Feb 2, 2022

    Tiotropium and Olodaterol in Comparison to Triple Therapy

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Tiotropium and Olodaterol (Tio+Olo)
    • Long-acting beta2-agonist and Inhaled corticosteroids (LABA and ICS)
    • Andover, Massachusetts
      HealthCore, Inc.
    Nov 12, 2021

    Pulmonary Disease, Chronic Obstructive Trial in New Zealand, Thailand, United Kingdom (400 microgrammes GSK961081, 1200

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • 400 microgrammes GSK961081
    • 1200 microgrammes GSK961081
    • Wellington, New Zealand
    • +3 more
    Sep 28, 2021

    Severe Chronic Obstructive Pulmonary Disease inReal World

    Completed
    • Chronic Obstructive Pulmonary Disease
    • beclomethasone / formoterol / glycopyrronium
    • Antwerp, Belgium
    • +14 more
    Nov 25, 2021

    COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))

    Completed
    • Chronic Obstructive Pulmonary Disease
    • Chongqing, Chongqing, China
      Daping Hospital
    Oct 22, 2020

    Spiolto® Respimat® Versus Triple Combination Therapy in Everyday

    Completed
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist
    • Triple combination of Free or fixed Long-acting muscarinic antagonist+ Long-acting beta2 adrenoceptor agonist + inhalative corticosteroids
    • Bad Sachsa, Germany
    • +74 more
    Nov 10, 2021

    Effectiveness of Triple Therapy in COPD

    Completed
    Has Results
    • Pulmonary Disease, Chronic Obstructive
    • Long-acting beta2-agonist-long-acting muscarinic antagonists-inhaled corticosteroids(LABA-LAMA-ICS)
    • Long-acting beta2-agonist-inhaled corticosteroids-long-acting muscarinic antagonists (LABA-LAMA)
    • London, United Kingdom
      Clinical Practice Research Datalink
    Nov 29, 2019

    Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting

    Withdrawn
    • Pulmonary Disease, Chronic Obstructive
    • Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
    • Fluticasone furoate/umeclidinium/vilanterol
    • Waterbury, Connecticut
    • +2 more
    Apr 21, 2020

    Pulmonary Disease, Chronic Obstructive Trial in Italy (Bronchodilator Agents)

    Terminated
    • Pulmonary Disease, Chronic Obstructive
    • Bronchodilator Agents
    • Bari, BA, Italy
    • +38 more
    Dec 23, 2022

    Asthma, Corticosteroid Trial in Incheon (Oral corticosteroids)

    Not yet recruiting
    • Asthma
    • Corticosteroid
    • Oral corticosteroids
    • Incheon, Gyeongki, Korea, Republic of
      Incheon St. Mary's Hospital
    Mar 3, 2023

    Xerostomia Trial in Paris (sialendoscopy)

    Recruiting
    • Xerostomia
    • sialendoscopy
    • Paris, Ile-de-France, France
      Groupe Hospitalier Paris Saint Joseph
    Dec 30, 2022